<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> (APL) were studied in 97 patients which had <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in young age (up to 46 years) </plain></SENT>
<SENT sid="1" pm="."><plain>These antibodies (Abs) were found in 25 patients (26%): Abs to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>--in 15 patients (60%), Abs to <z:e sem="disease" ids="C1403246" disease_type="Disease or Syndrome" abbrv="">lupoid</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in 18 from 24 patients (75%), Abs to <z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi>--in 4 from 13 patients (31%) </plain></SENT>
<SENT sid="2" pm="."><plain>Disorders of cerebral circulation (<z:chebi fb="8" ids="53090">DCC</z:chebi>) usually began at the age of 14-45 years and were characterized by <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> and by transitory <z:chebi fb="8" ids="53090">DCC</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>There was no correlation between the occlusion of extracranial arteries and their hemodynamic significant stenosis </plain></SENT>
<SENT sid="4" pm="."><plain>There was occlusion of intracranial arteries in 7 from 12 patients (58%) </plain></SENT>
<SENT sid="5" pm="."><plain>Other risk factors of the <z:hpo ids='HP_0001297'>stroke</z:hpo> development were also found in 19 patients (76%) together with Abs to phopholipids </plain></SENT>
<SENT sid="6" pm="."><plain>Other manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APLS) were observed in 68% of the patients: <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage of pregnancy</z:e> (63%), <z:mp ids='MP_0005048'>thrombosis</z:mp> of peripheric veins (16%), <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (32%), <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (28%) </plain></SENT>
<SENT sid="7" pm="."><plain>Comparison of APL+ and APL- patients revealed that transitory <z:chebi fb="8" ids="53090">DCC</z:chebi>, occlusion of intracranial arteries, intact extracranial arteries, widening or condensation of the cardial valves on echo-ECG, abortions, increase of ESR were significantly more frequently observed in the former group </plain></SENT>
<SENT sid="8" pm="."><plain>For confirmation of APLS diagnosis it was necessary to study simultaneously Abs to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and <z:e sem="disease" ids="C1403246" disease_type="Disease or Syndrome" abbrv="">lupoid</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Prophylaxis of repeated <z:chebi fb="8" ids="53090">DCC</z:chebi> in APLS included administration of both aspirin and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> of indirect action </plain></SENT>
</text></document>